Review The Forces Opposing Us Health Reform In The Last 100

Review The Forces Opposing Us Health Reform In The Last 100 Years P

Review the forces opposing U.S. health reform in the last 100 years. Post an analysis of one of the opposing forces that addresses each of the following questions. How has the opposing force selected complicated health reform efforts within the last 100 years? Be specific. Explain whether changing political climates have or have not affected the force selected.

Analyze how policymakers and policies have attempted to combat the opposing force and explain how successful their efforts have been. Explain how health reform will or will not impact the policy selected for your Final Project. (use of electronic health records (EHRs))

Paper For Above instruction

The landscape of U.S. health reform has been fraught with numerous opposing forces that have significantly shaped the trajectory of policy initiatives over the past century. Among these, the entrenched interests of the healthcare industry, particularly large healthcare providers, insurance companies, and pharmaceutical corporations, have consistently impeded comprehensive reform efforts. This analysis explores how the influence of healthcare industry stakeholders has complicated health reform, how political changes have affected this opposition, and how policymakers have endeavored to counteract these forces, specifically in the context of electronic health records (EHRs).

The opposition from the healthcare industry has historically complicated health reform by preserving the status quo to protect financial interests. During the 20th century, efforts such as the implementation of Medicare and Medicaid faced fierce lobbying campaigns aimed at limiting government intervention and maintaining profitability for private insurers and providers. For instance, the expansion of Medicaid under the Affordable Care Act (ACA) encountered significant resistance from insurance companies, which perceived reforms that aimed to reduce administrative costs and expand coverage as threats to their revenue models. The industry's typical argument has been that sweeping reforms would lead to increased costs, reduced reimbursements, and decreased market share. This opposition has often resulted in watered-down policies, delays, or outright legislative failure, reflecting the industry's significant political influence.

Changing political climates have undeniably influenced the degree and effectiveness of opposition from healthcare stakeholders. Republican administrations, historically more aligned with free-market principles, have often emphasized deregulation and privatization, which have aligned with industry interests, thereby strengthening opposition to reforms perceived as expansive or government-led. Conversely, Democratic administrations have tended to favor more regulation and publicly funded initiatives, though these efforts have still faced obstinate resistance from industry lobbyists. For example, during the passage of the ACA, bipartisan opposition from industry groups slowed reforms but also led to strategic compromises. Over time, shifts in political power have either amplified or subdued industry opposition, illustrating the dynamic nature of this force.

Policymakers have employed various strategies to curb the influence of healthcare industry opposition, particularly through regulation and incentives aimed at transparency and efficiency, such as the promotion of electronic health records (EHRs). The Health Information Technology for Economic and Clinical Health (HITECH) Act of 2009 exemplifies such efforts by incentivizing providers to adopt EHRs as a means to improve quality, reduce costs, and increase transparency. The adoption of EHRs has faced resistance from industry stakeholders concerned about costs, data security, and loss of control over patient information. Nonetheless, policymakers have attempted to address these concerns through grants, technical assistance, and standards development to facilitate implementation.

The success of these efforts is mixed. While the adoption of EHRs has significantly increased, driven by incentives and regulatory mandates, challenges remain concerning interoperability, data privacy, and the equitable distribution of technological advancements. The healthcare industry’s resistance has diminished somewhat due to the recognized benefits of EHRs in improving patient outcomes and operational efficiency, but industry opposition continues in various forms, such as lobbying against stricter data sharing regulations or advocating for proprietary systems that hinder interoperability.

Looking ahead, health reform initiatives—aimed at increasing access, reducing costs, and improving quality—will undoubtedly impact policies related to electronic health records. With ongoing emphasis on digital health, policies encouraging nationwide interoperability, data security, and patient-centered care are poised to reshape industry practices. The push for widespread EHR use aligns with reforms seeking greater transparency and efficiency, although industry opposition may persist in efforts to protect proprietary interests and data control. Ultimately, the continued evolution of health policies will need to navigate and mitigate industry opposition to realize the full potential of electronic health records in transforming healthcare delivery.

References

• Baicker, K., & Chandra, A. (2004). Medicare spending, the density of the physician workforce, and beneficiaries' quality of care. Health Affairs, 23(4), 103-114.
• Berwick, D. M., & Murphy, J. M. (2014). Performance improvement–How to achieve breakthrough improvement in health care. JAMA, 312(12), 1218-1219.
• Blumenthal, D., & Tavenner, M. (2010). The “meaningful use” regulation for electronic health records. New England Journal of Medicine, 363(6), 501-504.
• Centers for Medicare & Medicaid Services (CMS). (2019). EHR Incentive Programs. https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms
• Hall, M. A., & McGraw, S. A. (2014). Moving toward shared decision making in cardiovascular care: what's the role of health policy? Circulation: Cardiovascular Quality and Outcomes, 7(3), 387-389.
• Kho, A. N., et al. (2015). Interoperability in health information exchange: A review of current challenges and future solutions. Journal of Hospital Administration, 4(4), 50-58.
• Shortliffe, E. H., & Cimino, C. (2014). Biomedical Informatics: Computer Applications in Health Care and Biomedicine. Springer.
• Shapiro, J., et al. (2014). The impact of electronic health records on patient safety and quality of care. Medical Care Research and Review, 71(2), 157-179.
• Woolf, S. H., & Aron, L. (2013). U.S. health in international perspective: Shorter lives, poorer health. National Academies Press.
• Yoo, H., & Kim, S. (2016). Healthcare industry lobbying and policy-making: The case of electronic health records. Journal of Health Policy and Management, 4(2), 105-112.